Director dealings: Oxford Biodynamics director lowers stake

(Sharecast News) - Oxford Biodynamics revealed on Friday that Vulpes Testudo Fund had offloaded 777,000 ordinary shares in the AIM-listed biotechnology company. Vulpes Testudo, which is controlled by non-executive director Stephen Diggle, sold the shares on Wednesday at an average price of 38.30p each, for a total value of £297,590.99.

Following the transaction, Diggle holds an interest in a total of 27.55m OBD shares, representing approximately 13.62% of the company's current issued share capital.

Earlier in October, Oxford BioDynamics successfully secured a proprietary laboratory analysis (PLA) code from the American Medical Association's Current Procedural Terminology Editorial Board. OBD said the unique code pertained to its EpiSwitch prostate screening test, which boasts a 94% accuracy.

As of 1530 BST, Oxford Biodynamics shares were up 2.25% at 34.80p.





Reporting by Iain Gilbert at Sharecast.com



Top Director Buys

Everyman Media Group (EMAN) Director name: Rosehill,Michael Amount purchased: 2,500,000 @ 55.00p Value: �1,375,000.03

Oxford Cannabinoid Technologies Holdings (OCTP) Director name: Mahapatra,Indraneil (Neil) Amount purchased: 20,457,484 @ 0.81p Value: �165,705.62

888 Holdings (di) (888) Director name: Mendelsohn,Jonathan (Jon) Amount purchased: 50,000 @ 79.50p Value: �39,750.00

Top Director Sells

Ferguson (FERG) Director name: Murphy,Kevin Amount sold: 18,619 @ $164.54 Value: $2,526,213.08

Oxford Cannabinoid Technologies Holdings (OCTP) Director name: Mahapatra,Indraneil (Neil) Amount sold: 54,864,288 @ 0.81p Value: �444,400.74

Oxford Biodynamics (OBD) Director name: Diggle,Stephen Charles Amount sold: 777,000 @ 38.30p Value: �297,590.99